The Reptilian Secret Society is a "play-to-earn" NFT project and decentralized community built on the Hedera network. It’s centered around a fictional universe where a secret society of reptilian beings has infiltrated every aspect of human society.

‍

The core of the project is its series of NFT collections, starting with the "Genesis" collection of 10,000 reptilian characters. These NFTs serve as both digital collectibles and membership tokens, granting holders access to "The Syndicate," the project's decentralized autonomous organization (DAO). Ownership of these NFTs also provides access to various "play-to-earn" features, including the ability to stake NFTs to earn the project's native utility token. The ecosystem also includes a marketplace for trading the NFTs and a breeding mechanic that allows owners to create new "hybrid" NFTs.

‍

The Reptilian Secret Society uses the Hedera Token Service (HTS) to mint all of its NFTs and fungible tokens, which ensures low, predictable transaction fees and fast, secure transfers.

‍

The eftpos solution by Australian Payments Plus provides a cost effective, secure and flexible payment infrastructure for Australian businesses. It supports real time debit transactions, tap to pay on mobile devices, eftpos QR payments and least cost routing, which allows merchants to automatically direct debit transactions through the lowest cost network to help reduce the cost of acceptance.

‍

Australian Payments Plus has worked with Google to enable least cost routing in Google Wallet, with ANZ and Suncorp the first issuers to offer this capability. It is also partnering with Giesecke and Devrient to develop eftpos Click to Pay with integrated least cost routing, an online checkout service that uses tokenisation to protect card credentials and is scheduled for rollout from early 2026 following pilot trials.

‍

These developments enhance payment efficiency, improve security, support domestic data sovereignty and align with Reserve Bank of Australia findings that least cost routing can materially reduce merchant debit acceptance costs.

‍

Certara is a global leader in biosimulation, a technology that uses computer models to predict how drugs will behave in the human body. Founded in 2008 and headquartered in Princeton, New Jersey, its mission is to accelerate the development of new medicines by transforming the traditional drug discovery and development process.

‍

The company offers a comprehensive suite of software and services that are used by over 2,000 biopharmaceutical companies, academic institutions, and regulatory agencies in 62 countries. Certara's Simcyp Simulator, for example, is a physiologically-based pharmacokinetic (PBPK) modeling platform that is widely used to predict drug interactions. In addition to its software, Certara provides a range of consulting services, including regulatory science, market access, and medical writing.

‍

Certara's OpenPharma innovation has developed a decentralized application called Hasharc that is built on the Hedera network and designed to address key challenges in the life sciences industry, such as supply chain security, patient safety, and regulatory compliance.

‍